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Background: Acute intestinal infections (AII) represent one of
themost signiﬁcanthealthproblemsacross theworld.Among them
rotaviruses of group A (RV) and noroviruses (NV) play a leading
role in the structure of viral diarrhea in infants and children up to
5 years. The aim of this work was to study the genetic diversity
of noroviruses and rotaviruses circulating in different regions of
Ukraine.
Methods & Materials: It was examined 537 fecal samples from
children under the age of 5 years with AII in different geograph-
ical regions of Ukraine, representing north, south, east, west and
center of the country and collected during the autumn and win-
ter epidemic seasons of 2007–2012 yrs. (Fig. 1). Clinical specimens
were tested for the presence of RV and NV with RT-PCR methods,
ELISA and rapid tests based on immunochromatographic analysis.
Genotyping of positive sampleswas performed via RT-PCRwith set
of primers, speciﬁc for different RV and NV genotypes.
Results: Results of the study showed that in Ukraine during epi-
demic periods in average 32.7% of the etiological agents of AII were
NV with GI and GII genotypes, showing a signiﬁcant advantage of
GII genotype (77,52%) (Fig. 2). RV were etiological agents in 34% of
AII cases. Result of genotyping discovered diversity of four major
Fig. 1. Geographic areas of research.
Fig. 2. Genetic diversity of noroviruses in Ukraine.
Fig. 3. Genetic diversity of rotaviruses in Ukraine.
genotypes of rotaviruses group A: G1P[8], G4P[8], G3P[8], G2P[4],
with the dominance of genotype G1P[8] (32.8%) in the study period
(Fig. 3).
Conclusion: We characterize the genetic spectrum of NV and
RV circulating in Ukraine and their propagation characteristics in
different regions of the country. It was shown that RT-PCR is the
“gold standard” in the etiological diagnosis of AII, and simulta-
neous genotyping - the modern “tool” in the study of intestinal
viruses, which is especially important in the context of the imple-
mentation of the programs of epidemic disease surveillance and
prevention.
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Background: Hepatitis C virus (HCV) infection is an important
sociomedical problem worldwide, and in Croatia as well. The aim
of this study was to determine the differences in genotypes dis-
tribution of HCV in two risk groups, among prisoners and among
intravenous drug addicts in north-western Croatia. Because of the
dominant prevalence of genotype 3 in Croatian intravenous drug
users, it is expected that HCV genotype 3 will be more prevalent in
the intravenous drug addicts group than in the prisoners group in
studied geographic area. The data about HCV genotype distribution
in population of prisoners in Croatia are missing and generally the
most prevalent genotype is subtype 1b.
Methods & Materials: The study included 67 seropositive
patients with chronic HCV infection classiﬁed in two groups,
the ﬁrst group consisted of prisoners (n =32) and the second
one of intravenous drug addicts (n =35). The patients from both
groups underwent diagnostic procedures during 2010, when they
were all anti-HCV positive and they not received any antiviral
therapy. HCV RNA was detected from sera by using qualitative
(COBAS AMPLICOR Hepatitis C Virus Test v. 2.0) and quantita-
tive polymerase chain reaction (COBAS AMPLICOR HCV MONITOR
Test v. 2.0) and genotyped (LINEAR ARRAY HCV Genotyping
Test).
Results: HCV RNA was present in 52 of 67 samples (77.6%).
The 88.6% prevalence of HCV RNA among anti-HCV-positive intra-
venous drug addicts was signiﬁcantly higher than the 65.6%
prevalence of HCV RNA among seropositive prisoners (p <0.05).
HCV genotype 3 was signiﬁcantly more frequent among intra-
venous drug addicts than among prisoners (p <0.01) and it was the
predominant type in the intravenous addicts group (80.7%), while
genotype 1 and 3 were equally distributed in the prisoners group
